Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy

Condition:   Ovarian Cancer Intervention:   Drug: W_ova1 Vaccine Sponsors:   University Medical Center Groningen;   Biontech RNA Pharmaceuticals GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials